全文获取类型
收费全文 | 155995篇 |
免费 | 37069篇 |
国内免费 | 5402篇 |
专业分类
耳鼻咽喉 | 3021篇 |
儿科学 | 3169篇 |
妇产科学 | 2703篇 |
基础医学 | 8245篇 |
口腔科学 | 6588篇 |
临床医学 | 33637篇 |
内科学 | 30983篇 |
皮肤病学 | 3912篇 |
神经病学 | 14423篇 |
特种医学 | 5902篇 |
外国民族医学 | 28篇 |
外科学 | 23905篇 |
综合类 | 14041篇 |
现状与发展 | 59篇 |
一般理论 | 7篇 |
预防医学 | 18321篇 |
眼科学 | 3718篇 |
药学 | 7904篇 |
107篇 | |
中国医学 | 4769篇 |
肿瘤学 | 13024篇 |
出版年
2024年 | 802篇 |
2023年 | 5973篇 |
2022年 | 3692篇 |
2021年 | 6306篇 |
2020年 | 8284篇 |
2019年 | 4104篇 |
2018年 | 8933篇 |
2017年 | 9605篇 |
2016年 | 9902篇 |
2015年 | 11165篇 |
2014年 | 14301篇 |
2013年 | 15982篇 |
2012年 | 9519篇 |
2011年 | 9523篇 |
2010年 | 11281篇 |
2009年 | 12811篇 |
2008年 | 7555篇 |
2007年 | 5937篇 |
2006年 | 6708篇 |
2005年 | 4644篇 |
2004年 | 3079篇 |
2003年 | 2416篇 |
2002年 | 1987篇 |
2001年 | 2644篇 |
2000年 | 1903篇 |
1999年 | 2262篇 |
1998年 | 2358篇 |
1997年 | 2158篇 |
1996年 | 2173篇 |
1995年 | 1871篇 |
1994年 | 1210篇 |
1993年 | 1009篇 |
1992年 | 838篇 |
1991年 | 706篇 |
1990年 | 595篇 |
1989年 | 587篇 |
1988年 | 553篇 |
1987年 | 423篇 |
1986年 | 388篇 |
1985年 | 320篇 |
1984年 | 264篇 |
1983年 | 305篇 |
1982年 | 227篇 |
1981年 | 208篇 |
1980年 | 123篇 |
1979年 | 74篇 |
1978年 | 125篇 |
1977年 | 120篇 |
1976年 | 90篇 |
1974年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
3.
4.
5.
6.
7.
8.
9.
10.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献